|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date13 Jan 2016 |
|
MechanismSodium channels blockers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date29 Aug 2008 |
|
MechanismTNF-α inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date22 Apr 2008 |
100 Clinical Results associated with UCB Pharma BV
0 Patents (Medical) associated with UCB Pharma BV
100 Deals associated with UCB Pharma BV
100 Translational Medicine associated with UCB Pharma BV